Skip to content
Credit reportVerdict and grounds
Made on 21-11-2026 at 11:58
Reference CK-0872170748-20261121

DR. SCHEPERS

ActivePrivate limited company (pre-2019)0872.170.748Henri Decleenestraat 29, 3600 Genk
Specialist medical practice (NACE 86220) · founded in 2005 · 8th largest company by equity in Genk, Health and social work sector

Sources: the KBO register on 21-11-2026; the National Bank, 2025 annual accounts filed on 20-06-2026; the Belgian Official Gazette, latest deed of 02-02-2018.

Credit verdict
Checked score 2025
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
The median of 1,081 small companies in the human health sector (NACE 86) is below 0.1%.
Gross margin
€1.2m
▲ 3.0% against 2024
Net result
€721,138
▲ 0.6% against 2024
Equity
€4.9m
▲ 11.7% against 2024
Cash
€1.1m
▲ 40.3% against 2024

Grounds

the facts the verdict rests on, each with its source
  1. DR. SCHEPERS made a profit in every financial year since 2006.Annual accounts 2006 to 2025 page 2
  2. Equity stands at €4.9m, or 98.0% of the balance sheet total of €5.0m. The solvency of 98.0% is higher than at 95% of the 2,825 companies filing abbreviated accounts in human health (NACE 86) in 2025.Annual accounts 2025 page 2
  3. Cash rose from €802,015 to €1.1m. Debts due within one year fell from €123,347 to €95,334.Annual accounts 2024 and 2025 page 2
  4. The 2025 accounts reached the National Bank 41 days before the end of the term.National Bank, filing of 20-06-2026 page 5

Representation

The articles of association in the Belgian Official Gazette set who represents DR. SCHEPERS.

Ownership

is a shareholder.

Deed of 21-01-2014

DR. SCHEPERS · 0872.170.748 · credit report of 21-11-2026Page 1 of 6
DR. SCHEPERS0872.170.748 · report of 21-11-2026

Financial situation

Annual accounts 2021 to 2025, as filed with the National Bank

Gross margin and net resultin €m

20210.720220.920231.020241.120251.220210.420220.620230.620240.720250.7
gross marginnet result

Equity and debtsin €m

202120222023202420254.90.1
equitydebts

Cashin €m

20210.420220.320230.920240.820251.1
on the balance sheet date
Financial year20212022202320242025Trend
Results
Gross margin€686,851€948,236€979,125€1.1m€1.2m
Operating result€576,585€797,540€862,982€1.0m€1.0m
Net result€444,188€585,812€603,876€716,859€721,138
Balance sheet at the closing date
Equity€4.4m€3.7m€4.3m€4.4m€4.9m
Debts€32,213€47,369€86,029€127,797€99,364
Debts due within one year€28,086€43,369€81,579€123,347€95,334
Cash€421,086€281,500€910,540€802,015€1.1m
Balance sheet total€4.4m€3.7m€4.3m€4.5m€5.0m
Ratios
Solvency99.3%98.7%98.0%97.2%98.0%
Liquidity53.8321.7620.7315.8625.52

Source: Annual accounts 2025, abbreviated format, filed on 20-06-2026 (2026-00179168); Annual accounts 2024, abbreviated format, filed on 30-06-2025 (2025-00197760); Annual accounts 2021 to 2023, filed from 11-08-2022 to 05-07-2024 (2022-20282732, 2023-00253614, 2024-00212479).

Debts fell by €28,433 in 2025.

The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.

DR. SCHEPERS · 0872.170.748 · credit report of 21-11-2026Page 2 of 6
DR. SCHEPERS0872.170.748 · report of 21-11-2026

Board, signature and ownership

Position on 21-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

The articles of association in the Belgian Official Gazette set who represents DR. SCHEPERS.

Board

The office holders of DR. SCHEPERS are in the KBO register.

Ownership and group

Shareholders

is a shareholder.

Deed of 21-01-2014

DR. SCHEPERS · 0872.170.748 · credit report of 21-11-2026Page 3 of 6
DR. SCHEPERS0872.170.748 · report of 21-11-2026

Holdings

DR. SCHEPERS has 2 holdings (own 2025 accounts).

Country Company Equity Result
Belgium 2
BE 32.85% €729,543 result -€72,482
BE 20% €19,903 result -€16,870

Source: List of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.

DR. SCHEPERS · 0872.170.748 · credit report of 21-11-2026Page 4 of 6
DR. SCHEPERS0872.170.748 · report of 21-11-2026

Events and comparison

The latest events, newest first

Annual accounts 2025 filed, 41 days before the deadline.

NBB filing

Annual accounts 2024 filed, 31 days before the deadline.

NBB filing

Annual accounts 2023 filed, 26 days before the deadline.

NBB filing

Annual accounts 2022 filed, 11 days before the deadline.

NBB filing

Annual accounts 2021 filed, 11 days late.

NBB filing

Annual accounts 2020 filed, 24 days late.

NBB filing

Liquidity more than doubled. The current ratio rises from 68.54 to 148.81. Short-term debt falls from €21,852 to €11,946.

Financial

Annual accounts 2019 filed, 34 days late.

NBB filing

Annual accounts 2018 filed, 28 days late.

NBB filing

Annual accounts 2017 filed, 31 days late.

NBB filing

Capital decrease of €3,780,000 to €18,600. The capital fell from €3,798,600 to €18,600. General meeting of 18-01-2018.

Gazette, deed 18024754

Liquidity more than doubled. The current ratio rises from 79.38 to 187.41. Short-term debt falls from €61,922 to €27,531.

Financial

Annual accounts 2016 filed. On the deadline day.

NBB filing

Annual accounts 2015 filed, 31 days late.

NBB filing

Comparable companies, two years later

In July 2024, 20,148 companies had the same profile as DR. SCHEPERS has now: small, 20 years or older, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 95.0% were still trading, 4.8% had stopped another way and 0.2% had gone bankrupt.

still trading 95.0% stopped another way 4.8% bankrupt 0.2%

The return on assets of DR. SCHEPERS, 14.5%, is higher than at 53% of the 2,777 companies filing abbreviated accounts in human health (NACE 86) in 2025.

Other findings

Peppol

Reachable for e-invoices since 18-12-2025, under 0208:0872170748.

Sanctions lists

DR. SCHEPERS · 0872.170.748 · credit report of 21-11-2026Page 5 of 6
DR. SCHEPERS0872.170.748 · report of 21-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units21-11-2026KBO 0872.170.748
National Bank of BelgiumAnnual accounts 2025, abbreviated format20-06-20262026-00179168
National Bank of BelgiumAnnual accounts 2024, abbreviated format30-06-20252025-00197760
National Bank of BelgiumAnnual accounts 2021 to 202311-08-2022 to 05-07-20242022-20282732, 2023-00253614, 2024-00212479
Peppol DirectoryRegistration for e-invoices18-12-20250208:0872170748
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name19-11-2026
CheckedChecked score, bankruptcy probability, credit, comparable companies20-11-2026bankruptcy model of 2 October 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 20-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

DR. SCHEPERS · 0872.170.748 · credit report of 21-11-2026Page 6 of 6